<DOC>
	<DOC>NCT01497210</DOC>
	<brief_summary>The primary objective of this study is to evaluate the safety and preliminary performance of EASH dressing for 4 weeks followed by AQUACELÂ® dressing for 4 weeks on venous leg ulcers.</brief_summary>
	<brief_title>EASH Dressing on Chronic Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Subjects over 18 years, willing and able to provide written informed consent. Subjects who have an ankle to brachial pressure index (ABPI) of 0.8 or greater Subjects who have a venous leg ulcer (i.e. CEAP classification of C6 1), with duration less than 24 months and size ranging between 5 cm240 cm2. Subjects' leg ulcers will meet at least 3 of the 5 following clinical signs of infection: pain between two dressing changes, periulcer skin erythema/inflammation, oedema, malodour (foul odour), and heavy exudate. Subjects who agree to wear compression therapy daily in combination with the trial dressing. Subjects with a history of skin sensitivity to any of the components of the study product. Subjects who have had current local or systemic antibiotics in the week prior to inclusion with the exception of wounds that are considered to be clinically infected at baseline. Subjects whose leg ulcers are malignant, or who have had recent deep venous thrombosis or venous surgery within the last 3 months. Subjects who have progressive neoplastic lesion treated by radiotherapy or chemotherapy, or ongoing treatment with immunosuppressive agents Subjects exhibiting any other medical condition which, according to the Investigator, justifies the subject's exclusion from the study Subjects who have participated in a clinical study within the past month.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>